Gi track delivery systems

Patent metadata

Field	Value
Publication number	US-9592201-B2
Application number	US-57890304-A
Country	US
Kind code	B2
Filing date	Nov 22, 2004
Priority date	Nov 21, 2003
Publication date	Mar 14, 2017
Grant date	Mar 14, 2017

Abstract

A micro encapsulation material for use with storage unstable, therapeutic and nutritional agents which release the therapeutic and nutritional agents in predetermined locations in the gastro intestinal tract in which the microencapsulation material is formed by combining a food grade treated carbohydrate with a water soluble food grade protein. The therapeutic and nutritional agents form an oil phase which is emulsified with the water dispersed or dissolved encapsulant to encapsulate the therapeutic and nutritional agents. These agents may be oils or oil soluble or oil dispersible. The agents that may be encapsulated include lipids (oils including oxygen sensitive oils, fatty acids, triglycerides) and oil soluble and oil dispersible ingredients (including pharmaceuticals, probiotics, protein therapeutics and bioactives). The protein used may include any film forming water soluble protein or hydrolyzed protein and includes milk proteins such as casein and its derivatives or whey proteins. The carbohydrate component may be those containing reducing sugar groups, oligosaccharides and starches (raw, modified, resistant, acetylated, proprionylated and butylated starches).

First claim

The invention claimed is:

1. An encapsulated therapeutic or nutritional agent that is the product of a process comprising the steps of:
(A) treating a water-insoluble resistant starch to increase the number of sugar reducing groups in the resulting treated starch, wherein the treating is selected from the group consisting of heating, extrusion, high pressure processing, microfluidisation, and ultrasonication;
(B) forming a dispersion of a film-forming protein and the treated starch in an aqueous phase, wherein the dispersion has a protein:starch ratio of from about 1:1 to about 1:2;
(C) heating the dispersion to induce formation of Maillard reaction products;
(D) mixing a storage-unstable therapeutic or nutritional agent with the dispersion to form a mixture; and then
(E) homogenizing the mixture to obtain an agent-in-water emulsion,
wherein the treated starch and the film-forming protein encapsulate the agent with a protective shell, which shell allows release of the agent in the gastrointestinal tract.

2. The encapsulated therapeutic or nutritional agent of claim 1 , wherein the process further comprises spray drying the emulsion.

3. The encapsulated therapeutic or nutritional agent of claim 1 , wherein the film-forming protein includes milk proteins.

4. The encapsulated therapeutic or nutritional agent of claim 1 , wherein the agent comprises at least one agent selected from the group consisting of lipids, oil soluble, and oil dispersible ingredients.

5. The encapsulated therapeutic or nutritional agent of claim 1 , wherein the starch comprises wheat starch.

6. The encapsulated therapeutic or nutritional agent of claim 1 , wherein step (A) comprises microfluidisation.

7. The encapsulated therapeutic or nutritional agent of claim 1 , wherein step (A) comprises ultrasonication.

8. The encapsulated therapeutic or nutritional agent of claim 1 , wherein step (A) comprises treating the starch with high pressure processing.

9. The encapsulated therapeutic or nutritional agent of claim 1 , wherein the agent-in-water emulsion is comprised of at least 60% water.

10. An encapsulated therapeutic or nutritional agent that is the product of a process comprising the steps of:
(A) treating a water-insoluble resistant starch to increase the number of sugar reducing groups in the resulting treated starch, wherein the treating is selected from the group consisting of heating, extrusion, high pressure processing, microfluidisation, and ultrasonication;
(B) forming a dispersion of a film-forming protein and the treated starch in an aqueous phase;
(C) heating the dispersion to induce formation of Maillard reaction products;
(D) mixing a storage-unstable therapeutic or nutritional agent with the dispersion to form a mixture; and then
(E) homogenizing the mixture to obtain an agent-in-water emulsion that is comprised of at least 60% water, wherein the treated starch and the film-forming protein encapsulate the agent with a protective shell, which shell allows release of the agent in the gastrointestinal tract.

11. The method of claim 1 , wherein the water-insoluble resistant starch is an RS2 or RS3 starch.

Assignees

• Head Richard
• Sanguansri Luz
• Augustin Mary Ann
• Commw Scient Ind Res Org

Inventors

• Head Richard
• Sanguansri Luz
• Augustin Mary Ann

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A23V2002/00

  Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

• A23D9/05

  Forming free-flowing pieces · CPC title

• A61K9/5036

  Polysaccharides, e.g. gums, alginate; Cyclodextrin · CPC title